E*TRADE from Morgan Stanley · 1 month ago
Investment Banking Healthcare Vice Presidents – New York
E*TRADE from Morgan Stanley is seeking Vice Presidents to join their Healthcare Investment Banking Group in New York City. The role involves working on complex transactions including mergers, acquisitions, and strategic advisory assignments while collaborating with professionals across the firm to deliver high quality advice to clients.
BankingFinanceFinancial Services
Responsibilities
Work with regional and international clients on a wide range of complex transactions including acquisitions, divestitures, mergers, joint ventures, corporate restructurings, shareholder relations, recapitalizations, demergers, leveraged buyouts and defenses against unsolicited takeover attempts, strategic advisory assignments and executions of public and private capital markets transactions
Work closely with professionals throughout the firm to deliver high quality advice to our clients
Play an important role on a team that includes senior professionals who will encourage you to go beyond the numbers and think creatively
Qualification
Required
6+ years of relevant experience within the investment banking industry, or 3.5+ years of post-MBA experience, with a proven track record working on complex executed deals across M&A and various industry sectors
Strong written and verbal communication, client and interpersonal skills
Commercial instinct and ability to perform under pressure and tight deadlines
Bachelor's degree required; an MBA and/or CFA designation would be an asset
Series licensing or must obtain
Preferred
Experience in the healthcare industry, ideally in Biopharma, Medtech, or Pharma Services is strongly preferred, but not required
Benefits
Commission earnings
Incentive compensation
Discretionary bonuses
Other short and long-term incentive packages
Other Morgan Stanley sponsored benefit programs
Company
E*TRADE from Morgan Stanley
E*TRADE from Morgan Stanley is a pioneer in the online brokerage industry.
Funding
Current Stage
Public CompanyTotal Funding
unknown2020-02-20Acquired
1996-08-16IPO
Recent News
2025-11-07
2025-10-14
Company data provided by crunchbase